HIV/AIDS Prevention
Findings from National Institute for Health Development provide new insights into HIV/AIDS prevention
Published in AIDS Weekly, April 5th, 2010
Current study results from the report, 'HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention,' have been published. According to a study from Tallinn, Estonia, "Following a heroin shortage, fentanyl and 3-methylfentanyl, known as 'China White' and 'White Persian', have become the most widely used drugs, along with amphetamine, among injecting drug users (IDUs) in Tallinn, Estonia. In order to assess the relationships between the injection of fentanyl and amphetamine, and levels of HIV prevalence and risk behaviour, 350 current IDUs were recruited using respondent-driven sampling for an interviewer-administered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-04-05)
More Articles from AIDS Weekly
- Rush University Medical Center
Community acquired MRSA infection rates are 6 times greater in HIV patients - Antiretrovirals
New antiretrovirals research from S. Rajasekaran et al outlined - Argos Therapeutics
Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis(TM) HIV Program on Viral Genetic Diversity - Cancer Gene Therapy
Scientists at National Cancer Institute report research in cancer gene therapy - Central Nervous System
Study results from N. Kumari and colleagues update understanding of central nervous system - Chronic Hepatitis B Virus
Investigators at Yonsei University, Medical Department target chronic hepatitis B virus - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
